Axsome Therapeutics AXSM has outperformed the market over the past 5 years by 62.16% on an annualized basis producing an average annual return of 69.55%. Currently, Axsome Therapeutics has a market capitalization of $3.18 billion.
Buying $100 In AXSM: If an investor had bought $100 of AXSM stock 5 years ago, it would be worth $1,401.15 today based on a price of $73.21 for AXSM at the time of writing.
Axsome Therapeutics's Performance Over Last 5 Years
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.